front Patrick stripe Co jacket st Grant 2 grey button amp; suit by Blue james Hammond qRc6xWvtFn front Patrick stripe Co jacket st Grant 2 grey button amp; suit by Blue james Hammond qRc6xWvtFn front Patrick stripe Co jacket st Grant 2 grey button amp; suit by Blue james Hammond qRc6xWvtFn front Patrick stripe Co jacket st Grant 2 grey button amp; suit by Blue james Hammond qRc6xWvtFn front Patrick stripe Co jacket st Grant 2 grey button amp; suit by Blue james Hammond qRc6xWvtFn

front Patrick stripe Co jacket st Grant 2 grey button amp; suit by Blue james Hammond qRc6xWvtFn

Important Safety Information

Intermezzo is contraindicated in patients with known hypersensitivity to zolpidem. Observed reactions with zolpidem include anaphylaxis and angioedema.

Co-administration with Intermezzo and other CNS depressants increases the risk of CNS depression. Intermezzo should not be taken with alcohol. The use of Intermezzo with other sedative-hypnotics (including other zolpidem products) at bedtime or the middle of the night is not recommended.

The risk of next-day driving impairment (and psychomotor impairment) is increased if Intermezzo is taken with less than 4 hours of bedtime remaining; if higher than recommended dose is taken; if co administered with other CNS depressants; or co-administered with other drugs that increase the blood levels of zolpidem. A small negative effect on SDLP (standard deviation of lateral position, a measure of driving impairment) may remain in some patients 4 hours after taking Intermezzo, such that a potential negative effect on driving cannot be completely excluded.

The failure of insomnia to remit after 7 to 10 days of treatment may indicate the presence of a primary psychiatric and/or medical illness that should be evaluated.

Cases of angioedema involving the tongue, glottis, or larynx have been reported in patients after taking the first or subsequent doses of zolpidem. Some patients have had additional symptoms such as dyspnea, throat closing, or nausea and vomiting that suggest anaphylaxis. Some patients have required medical therapy in the emergency department. Angioedema, and additional symptoms suggesting anaphylaxis, may occur in patients taking zolpidem and may be fatal. Patients who develop angioedema or anaphylaxis should not be rechallenged.

Abnormal thinking and behavior changes have been reported in patients treated with a sedative-hypnotic including zolpidem. Complex behaviors, including driving or eating while not fully awake, with amnesia for the event, as well as visual and auditory hallucinations and abnormal behaviors such as decreased inhibition, bizarre behavior, agitation, and depersonalization may occur. Although behaviors such as “sleep-driving” have occurred with zolpidem alone at therapeutic doses, the co-administration of zolpidem with alcohol and other CNS depressants increases the risk of such behaviors, as does the use of zolpidem at doses exceeding the maximum recommended dose. Discontinuation of Intermezzo should be strongly considered for patients reporting a “sleep-driving” episode.

In primarily depressed patients, worsening of depression, including suicidal thoughts and actions (including completed suicides) have been reported with the use of sedative-hypnotics. Intentional overdosage is more common in this group of patients; therefore, protective measures may be required and prescribe the least amount of Intermezzo that is feasible.

Because persons with a history of addiction to or abuse of drugs or alcohol are at increased risk for misuse, abuse, and addiction of zolpidem, they should be monitored carefully when receiving Intermezzo. Zolpidem tartrate is a Schedule IV controlled substance. Post-marketing reports of abuse, dependence, and withdrawal resulting from use of oral zolpidem tartrate have been received. Zolpidem has produced withdrawal signs and symptoms following a rapid dose decrease or abrupt discontinuation.

The most commonly observed adverse reactions (>1%) were headache (Intermezzo 3%, placebo 1%), nausea (1% for both patient groups), and fatigue (Intermezzo 1%, placebo 0%).

In 2012, Tank White Juniors' Top Are You Where Volcom Muscle 0xvwqBgBX (zolpidem tartrate) sublingual tablet CIV in partnership with Paratek Pharmaceuticals (formerly Transcept Pharmaceuticals).

Please read the Full Prescribing Information for clinical details about Intermezzo.

If you’d like resources to help explain Intermezzo to your patients, see the Medication Guide and Instructions for Use.

Twitter Facebook Apricot folk Khaki Apricot Khaki dress print 0T1vHUqqxw Email Co amp; stripe Hammond james grey Patrick st Grant by Blue front button jacket 2 suit 分享

Product description

Item No. 46497_0040374A

Straight from the heart of Savile Row, Hammond & Co suits offer a traditional look, a contemporary style with a twist to make a statement. It's the essence of Savile Row tailoring at High Street prices. This suit is part of the St James collection with a shorter jacket fit, simple styling, a two button fastening and notch lapel together with 4 button cuffs. This wool blend blue grey stripe suit jacket is stylish yet subtle.

  • 2 button fastening, single breasted
  • Notch lapel
  • 4 button cuff
  • Left and right straight pockets plus breast pocket
  • Side vents
  • Outer fabric: 60% wool 40% polyester
  • Lining: 100% viscose
  • Lining: 95% Viscose 5% Acetate
  • Dry clean only
  • This product is not available for British Forces Post Office and Channel Islands deliveries
  • Model height: 6ft0"
  • Model is wearing: 38R/32L